Trust Company of Oklahoma’s Novartis NVS Stock Holding History

Trust Company of Oklahoma’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.68M	Sell	10,723 -604	-5%	-$90.5K	0.43%	45
2026 Q1	$1.73M	Sell	11,327 -153	-1%	-$23.5K	0.5%	43
2025 Q4	$1.58M	Sell	11,480 -338	-3%	-$44.3K	0.46%	46
2025 Q3	$1.52M	Buy	11,818 +107	+0.9%	+$13.1K	0.45%	49
2025 Q2	$1.42M	Sell	11,711 -38	-0.3%	-$4.28K	0.45%	52
2025 Q1	$1.31M	Sell	11,749 -149	-1%	-$15.9K	0.45%	50
2024 Q4	$1.16M	Buy	11,898 +177	+2%	+$18.9K	0.37%	56
2024 Q3	$1.35M	Sell	11,721 -185	-2%	-$21K	0.44%	51
2024 Q2	$1.27M	Sell	11,906 -168	-1%	-$16.9K	0.45%	55
2024 Q1	$1.17M	Sell	12,074 -24	-0.2%	-$2.46K	0.41%	55
2023 Q4	$1.22M	Buy	12,098 +518	+4%	+$50K	0.46%	54
2023 Q3	$1.18M	Buy	11,580 +1,253	+12%	+$127K	0.47%	51
2023 Q2	$1.04M	Sell	10,327 -85	-0.8%	-$8.5K	0.39%	60
2023 Q1	$958K	Sell	10,412 -1,096	-10%	-$95.7K	0.37%	60
2022 Q4	$1.04M	Buy	11,508 +4	+0%	+$337	0.42%	58
2022 Q3	$874K	Sell	11,504 -29	-0.3%	-$2.4K	0.44%	54
2022 Q2	$975K	Sell	11,533 -948	-8%	-$83.2K	0.46%	54
2022 Q1	$1.1M	Buy	12,481 +125	+1%	+$10.8K	0.42%	55
2021 Q4	$1.08M	Sell	12,356 -293	-2%	-$24.3K	0.37%	59
2021 Q3	$1.03M	Sell	12,649 -37	-0.3%	-$3.33K	0.37%	61
2021 Q2	$1.16M	Sell	12,686 -457	-3%	-$40.7K	0.39%	59
2021 Q1	$1.12M	Sell	13,143 -126	-0.9%	-$11.3K	0.4%	58
2020 Q4	$1.25M	Sell	13,269 -303	-2%	-$26.5K	0.46%	51
2020 Q3	$1.18M	Buy	+13,572	New	+$1.18M	0.49%	46
2020 Q1	$1.17M	Sell	14,225 -200	-1%	-$17.8K	0.61%	37
2019 Q4	$1.37M	Buy	14,425 +406	+3%	+$36.4K	0.54%	42
2019 Q3	$1.22M	Sell	14,019 -164	-1%	-$14.7K	0.53%	44
2019 Q2	$1.3M	Sell	14,183 -1,549	-10%	-$131K	0.58%	42
2019 Q1	$1.36M	Sell	15,732 -744	-5%	-$59.7K	0.62%	39
2018 Q4	$1.27M	Sell	16,476 -279	-2%	-$21.7K	0.67%	40
2018 Q3	$1.29M	Sell	16,755 -166	-1%	-$12.3K	0.59%	41
2018 Q2	$1.15M	Sell	16,921 -3,102	-15%	-$214K	0.57%	46
2018 Q1	$1.45M	Sell	20,023 -540	-3%	-$41.1K	0.7%	40
2017 Q4	$1.55M	Sell	20,563 -382	-2%	-$28.8K	0.74%	40
2017 Q3	$1.61M	Buy	20,945 +157	+0.8%	+$11.9K	0.8%	40
2017 Q2	$1.55M	Buy	20,788 +208	+1%	+$14.7K	0.8%	39
2017 Q1	$1.37M	Sell	20,580 -669	-3%	-$44.6K	0.71%	39
2016 Q4	$1.39M	Sell	21,249 -1,540	-7%	-$99.9K	0.74%	38
2016 Q3	$1.61M	Buy	22,789 +520	+2%	+$37.9K	0.89%	34
2016 Q2	$1.65M	Sell	22,269 -167	-0.7%	-$11.5K	0.91%	33
2016 Q1	$1.46M	Sell	22,436 -7,409	-25%	-$504K	0.81%	37
2015 Q4	$2.3M	Sell	29,845 -4,201	-12%	-$334K	1.28%	22
2015 Q3	$2.8M	Buy	34,046 +1,617	+5%	+$144K	1.62%	18
2015 Q2	$2.86M	Buy	32,429 +539	+2%	+$49.4K	1.51%	20
2015 Q1	$2.82M	Sell	31,890 -25,889	-45%	-$2.3M	1.39%	22
2014 Q4	$4.83M	Buy	57,779 +30,997	+116%	+$2.57M	2.38%	11
2014 Q3	$2.26M	Buy	26,782 +1,565	+6%	+$127K	1.13%	27
2014 Q2	$2.05M	Buy	25,217 +5,030	+25%	+$396K	0.99%	32
2014 Q1	$1.54M	Buy	20,187 +1,681	+9%	+$122K	1%	34
2013 Q4	$1.33M	Buy	18,506 +1,425	+8%	+$99.1K	0.89%	40
2013 Q3	$1.17M	Buy	17,081 +1,617	+10%	+$107K	0.87%	41
2013 Q2	$980K	Buy	+15,464	New	+$1.01M	0.76%	46

Other funds holding NVS

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

GGI

Godsey & Gibb Inc Richmond, Virginia $1.22B AUM 27.93% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Trust Company of Oklahoma's NVS Position: Q2 2026 in Review

Trust Company of Oklahoma reduced its Novartis (NVS) stake by 5.3% in Q2 2026, selling an estimated $90.5K and leaving 10,723 shares worth $1.68M. The position accounts for 0.43% of the portfolio, ranked #45.

Trust Company of Oklahoma first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.83M in Q4 2014. 734 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Trust Company of Oklahoma held 10,723 shares of Novartis worth $1.68M as of Q2 2026.
Trust Company of Oklahoma sold 604 Novartis shares in Q2 2026, an estimated $90.5K.
Novartis made up 0.43% of Trust Company of Oklahoma's portfolio in Q2 2026, its #45 holding.
Trust Company of Oklahoma first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
Trust Company of Oklahoma's Novartis position peaked at $4.83M in Q4 2014.
734 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Trust Company of Oklahoma's 13F filing for Q2 2026, filed 14 Jul 2026.